IBM, Confluent
Digest more
MarketBeat on MSN
Big Blue's Big Bet: IBM Buys AI Nervous System for $11B
On Dec. 8, 2025, International Business Machines (NYSE: IBM) announced one of its most significant strategic moves in years, entering a definitive agreement to acquire data-streaming pioneer Confluent (NASDAQ: CFLT).
IBM’s stock doubled but faces rising debt, slow growth, and high valuation. Click here to explore why IBM’s M&A strategy may limit gains despite AI optimism.
Its partnership with AMD can accelerate the commercialization of its quantum computing capabilities. The launch of Digital Asset Haven positions IBM as a key player in the fast-growing tokenization market. IBM is also seeing solid traction in its ...
IBM proves AI impact comes from redesigning work and culture, with leaders and employees driving change, not from new tools alone.
Get the latest on IBM's Q3 2025 performance, dividend outlook, and valuation insights. See here to know if IBM stock is a buy or hold.
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Alex Ossola: Hey, What's News listeners, it's Sunday, September 21st. I'm Alex Ossola for the Wall Street Journal. This is What's News ...